4//SEC Filing
PROVECTUS BIOPHARMACEUTICALS, INC. 4
Accession 0001140361-15-002672
$PVCTCIK 0000315545operating
Filed
Jan 25, 7:00 PM ET
Accepted
Jan 26, 1:05 PM ET
Size
8.8 KB
Accession
0001140361-15-002672
Insider Transaction Report
Form 4
WACHTER ERIC PHD
DirectorVice President Pharmaceuticals
Transactions
- Exercise/Conversion
Common Stock
2015-01-24$1.02/sh+185,000$188,700→ 824,248 total(indirect: By 401(k)) - Exercise/Conversion
Employee Stock Option (right to buy)
2015-01-24−185,000→ 800,000 totalExercise: $1.02From: 2006-06-23Exp: 2016-06-23→ Common Stock (185,000 underlying)
Holdings
- 4,867(indirect: By Trust)
Common Stock
- 5,393,236
Common Stock
Footnotes (1)
- [F1]The Reporting Person's Form 4 filed with the Commission on March 24, 2014 incorrectly reported 639,248 shares of the Issuer's common stock as held directly by the Reporting Person when it should have been reported as indirectly held by the Reporting Person through his 401(k) Plan. This Form 4 accurately reports the number of shares held directly and indirectly by the Reporting Person.
Documents
Issuer
PROVECTUS BIOPHARMACEUTICALS, INC.
CIK 0000315545
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000315545
Filing Metadata
- Form type
- 4
- Filed
- Jan 25, 7:00 PM ET
- Accepted
- Jan 26, 1:05 PM ET
- Size
- 8.8 KB